Lixivaptan is a selective vasopressin V2 receptor antagonist that has been investigated for its potential to treat conditions such as hyponatremia and autosomal dominant polycystic kidney disease. As a… Read more
Lixivaptan is a selective vasopressin V2 receptor antagonist that has been investigated for its potential to treat conditions such as hyponatremia and autosomal dominant polycystic kidney disease. As a member of the vaptan class of pharmaceuticals, this compound functions by inhibiting the binding of arginine vasopressin at renal collecting ducts to promote aquaresis. Our category of Lixivaptan reference standards provides researchers and laboratories with high-quality materials, including the parent drug, its specific impurities, related metabolites, and stable isotope labelled compounds. These products are essential for rigorous analytical testing, including impurity profiling, method validation, and quality control during pharmaceutical development. By providing precise, well-characterized reference materials, this collection supports scientists in ensuring accurate assessment of drug substance and product integrity throughout the research and development lifecycle, ultimately facilitating consistent results in complex analytical workflows.